MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Sanofi Stock

Sanofi

SNYNASDAQMarkt
US$40.61
+0.8% today

Company data

Sector
Healthcare
Industry
Drug Manufacturers - General
Country
France
CEO
Belén Garijo López
Employees
76,493
Market cap
$97.3 B
IPO
01/07/2002

Sanofi operates as a leading global pharmaceutical enterprise, dedicated to the research, development, production, and distribution of a wide array of therapeutic solutions across the United States, Europe, and numerous international markets. The company strategically organizes its operations into three core…

Sanofi stock: price history

16/10/25-18.8 %16/10/26

1D

+0.8%

1W

+1.3%

1M

-4.6%

6M

-15.5%

YTD

-16.2%

1Y

-18.8%

2Y

-25.4%

5Y

-16.9%

10Y

+7.6%

Next earnings date

Next earnings date

30/10/2026 (in 13 days)

Volatility around earnings

~49% stronger price swings than usual

Sanofi stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.

Ask the agents about Sanofi

Analyst assessment of Sanofi

PRICE TARGET LOW

US$49.00

CONSENSUS

US$49.50

MEDIAN

US$49.50

PRICE TARGET HIGH

US$50.00

0

STRONG BUY

12

BUY

14

HOLD

1

SELL

0

STRONG SELL

27

TOTAL · Hold

As of: 01/05/2026

ANALYST FIRMRATINGACTIONDATE
Morgan StanleyOverweight → Equal Weightdowngrade01/05/2026
Exane BNP ParibasOutperform → Neutraldowngrade20/04/2026
B of A SecuritiesBuy → Neutraldowngrade12/02/2026
UBSBuy → Neutraldowngrade16/01/2026
BarclaysOverweight → Equal Weightdowngrade06/01/2026
GuggenheimBuy → Neutraldowngrade09/12/2025
JP MorganOverweight → Neutraldowngrade08/12/2025
Morgan StanleyEqual Weight → Overweightupgrade08/09/2025 (older than 12 months)

Sanofi stock metrics

P/E

22

P/B

1.24

EV/EBITDA

7.4

RETURN ON EQUITY

0.5%

NET MARGIN

2.8%

DEBT/EQUITY

0.34

DIVIDEND YIELD

11.6%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

90.2%

FLOAT SHARES

2,160,286,184

AVG. DAILY VOLUME (30D)

3,147,695

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: +0.8%

Forums (Reddit)

26/0927/0906/10

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
DAVENPORT & Co LLC1,990,147-11,30430/09/2026
Atria Investments, Inc143,750+38,09530/09/2026
Sound Income Strategies, LLC92,404+1,44730/09/2026
Baker Ellis Asset Management LLC81,376+3430/09/2026
FULTON BANK, N.A.73,009+4,81330/09/2026
Page 1 / 3

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
04/05/202603/06/2026US$2.425.6 %
09/05/202512/06/2025US$2.204.4 %
09/05/202406/06/2024US$2.044.2 %
30/05/202323/06/2023US$1.903.8 %
26/05/202227/06/2022US$0.303.7 %
Page 1 / 6

Stock splits

DATERATIO
30/09/20135:1
17/11/201010:1

Smart Money

Register for free

Register now to see which funds are invested

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Comparable stocks

Frequently asked questions about Sanofi stock

What does Sanofi do?

Sanofi is a company in the Healthcare sector, Drug Manufacturers - General industry, headquartered in France.

The CEO is Belén Garijo López, the company employs around 76,493 people.

The IPO was on 01/07/2002; the stock trades on NASDAQ under the ticker SNY.

What do analysts say about Sanofi stock?

27 analysts rate the stock, the consensus is Hold (as of 01/05/2026).

The average price target is US$49.50, ranging from US$49.00 to US$50.00, with a median of US$49.50.

This is an external assessment, not a statement by Market Jury.

When does Sanofi report next?

The next earnings date is 30/10/2026.

Around past earnings, price swings were roughly 49% stronger than usual.

Does Sanofi pay a dividend?

Yes. The last dividend was US$2.42 per share, ex-date 04/05/2026, paid on 03/06/2026.

The dividend yield is 11.6% (as of 30/06/2026).

Which stocks are comparable to Sanofi?

Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, Roche Holding, Amgen, Gilead Sciences and Pfizer.

How can I get Sanofi stock analyzed?

Clicking "Analyze stock" lets five strategies assess Sanofi against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.